RNS Number : 6087D

Accrol Group Holdings PLC

04 March 2022

4 March 2022

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Accrol Group Holdings plc

("Accrol" or the "Company")

Director Dealing

Accrol (AIM:ACRL), the UK's leading independent tissue convertor, announces that Dan Wright, Executive Chairman of Accrol, has purchased 1,000,000 ordinary shares of GBP0.001 each ("Ordinary Shares") at an average price of 19.5875p per Ordinary Share.

Following this purchase, he now holds 12,515,543* Ordinary Shares representing approximately 3.9% of the current Issued Share Capital of the Company.

 *   10,786,972 of these shares are registered in the name of 
      Gomrath Limited, a family investment company controlled 
      by Dan Wright 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

       Details of the person discharging managerial 
  1     responsibilities / person closely associated 
 a)    Name                    Dan Wright 
      ----------------------  ---------------------------- 
 2     Reason for the notification 
 a)    Position/status         Executive Chairman 
      ----------------------  ---------------------------- 
 b)    Initial notification    Initial notification 
      ----------------------  ---------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, 
        auctioneer or auction monitor 
 a)    Name                    Accrol Group Holdings plc 
      ----------------------  ---------------------------- 
 b)    LEI                     213800MC56M5G69RJ226 
      ----------------------  ---------------------------- 
 4     Details of the transaction(s): section 
        to be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) 
        each date; and (iv) each place where 
        transactions have been conducted 
 a)    Description             Ordinary shares of GBP0.001 
        of the financial        each 
        type of instrument 
        code                    ISIN: GB00BZ6VT592 
      ----------------------  ---------------------------- 
 b)    Nature of               Purchase of Ordinary Shares 
        the transaction 
      ----------------------  ---------------------------- 
 c)    Price(s) and              Price(s)   Volume(s) 
        volume(s)                 1 9.5p     750,000 
                                   19.85p     250,000 
      ----------------------  ---------------------------- 
 d)     information 
   - Aggregated 
    volume                      1,000,000 
   - Price                      19.5875p 
 ---------------------------  ---------------------------- 
 e)    Date of the             3 March 2022 
      ----------------------  ---------------------------- 
 f)    Place of the            London Stock Exchange, AIM 
      ----------------------  ---------------------------- 
For further information, please contact: 
Accrol Group Holdings plc 
Dan Wright, Executive Chairman            Via Belvedere Communications 
Gareth Jenkins, Chief Executive Officer 
 Richard Newman, Chief Financial Officer 
Zeus Capital Limited (Nominated Adviser 
 & Broker) 
Dan Bate / Jordan Warburton                  Tel: +44 (0) 161 831 1512 
Dominic King                                 Tel: +44 (0) 203 829 5000 
Liberum Capital Limited (Joint Broker)       Tel: +44 (0) 20 3100 2222 
Clayton Bush / Edward Thomas 
Belvedere Communications Limited 
Cat Valentine                                Tel: +44 (0) 7715 769 078 
Keeley Clarke                                Tel: +44 (0) 7967 816 525 
Llew Angus                                   Tel: +44 (0) 7407 023 147 

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the GBP2.1bn UK retail tissue market.

For more information, please visit www.accrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

March 04, 2022 02:00 ET (07:00 GMT)

Accrol (LSE:ACRL)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Accrol Charts.
Accrol (LSE:ACRL)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Accrol Charts.